NCT02304198View on ClinicalTrials.gov

Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Udenafil

Udenafil 50mg tablet

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT02304198 - Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH | Biotech Hunter | Biotech Hunter